UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reply: ‘Comment on Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)’

British journal of cancer, 2013-10, Vol.109 (9), p.2506-2506

Katsumata, N

2013

Volltextzugriff (PDF)

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions

Annals of oncology, 2017-04, Vol.28 (4), p.711-717

2017

Volltextzugriff (PDF)

Dose-dense therapy is of benefit in primary treatment of ovarian cancer? In favor

Annals of oncology, 2011-12, Vol.22 Suppl 8, p.viii29-viii32

Katsumata, N

2011

Volltextzugriff (PDF)

Docetaxel: an alternative taxane in ovarian cancer

British journal of cancer, 2003-12, Vol.89 (S3), p.S9-S15

Katsumata, N

2003

Volltextzugriff (PDF)

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Annals of oncology, 2013-04, Vol.24 (4), p.1067-1073

2013

Volltextzugriff (PDF)

Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)

British journal of cancer, 2013-05, Vol.108 (10), p.1957-1963

2013

Volltextzugriff (PDF)

Association between blood omega-3 polyunsaturated fatty acids and the gut microbiota among breast cancer survivors

Beneficial microbes, 2019-10, Vol.10 (7), p.751-758

2019

Volltextzugriff (PDF)

FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer

Annals of oncology, 2011-06, Vol.22 (6), p.1302-1307

2011

Volltextzugriff (PDF)

Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: An international collaborative meta-analysis

European journal of surgical oncology, 2013-02, Vol.39 (2), p.115-124

2013

Volltextzugriff (PDF)

Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)

Annals of oncology, 2011-03, Vol.22 (3), p.636-642

2011

Volltextzugriff (PDF)

Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer

British journal of cancer, 2009-11, Vol.101 (9), p.1529-1536

2009

Volltextzugriff (PDF)

Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II–IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016)

Annals of oncology, 2014-01, Vol.25 (1), p.251-257

2014

Volltextzugriff (PDF)

Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)

Annals of oncology, 2009-07, Vol.20 (7), p.1210-1215

2009

Volltextzugriff (PDF)

Foraging areas of streaked shearwaters in relation to seasonal changes in the marine environment of the Northwestern Pacific: inter-colony and sex-related differences

Marine ecology. Progress series (Halstenbek), 2011-03, Vol.424, p.191-204

2011

Volltextzugriff (PDF)

Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy

British journal of cancer, 2010-07, Vol.103 (3), p.297-302

2010

Volltextzugriff (PDF)

Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus

British journal of cancer, 2003-01, Vol.88 (2), p.245-250

2003

Volltextzugriff (PDF)

A Phase III Trial of Paclitaxel plus Carboplatin Versus Paclitaxel plus Cisplatin in Stage IVB, Persistent or Recurrent Cervical Cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)

Japanese journal of clinical oncology, 2010-01, Vol.40 (1), p.90-93

2010

Volltextzugriff (PDF)

Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients

The European respiratory journal, 2011-12, Vol.38 (6), p.1425-1430

2011

Volltextzugriff (PDF)

Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer

Annals of oncology, 2011-06, Vol.22 (6), p.1353-1357

2011

Volltextzugriff (PDF)

Comparison between triplet antiemetic study (TTT) and doublet antiemetic study (PROTECT): insights into the mechanisms of serotonin and aprepitant actions in chemotherapy induced nausea and vomiting

Breast (Edinburgh), 2017-03, Vol.32, p.S26-S26

2017

Volltextzugriff (PDF)

Investigator-Initiated Clinical Trials for New Drugs in Japan: Challenges and Perspectives

Annals of oncology, 2012-10, Vol.23, p.xi14

Katsumata, N.

2012

Volltextzugriff (PDF)

Can oncologists predict survival for patients with progressive disease after standard chemotherapies?

Current oncology (Toronto), 2014-04, Vol.21 (2), p.84-90

2014

Volltextzugriff (PDF)

Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study

British journal of cancer, 2005-10, Vol.93 (9), p.999-1004

2005

Volltextzugriff (PDF)

Compound Heterozygous Mutations in the Cholesterol Side-Chain Cleavage Enzyme Gene (CYP11A) Cause Congenital Adrenal Insufficiency in Humans

The journal of clinical endocrinology and metabolism, 2002-08, Vol.87 (8), p.3808-3813

2002

Volltextzugriff (PDF)

Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy

Annals of oncology, 2010-11, Vol.21 (11), p.2195-2200

2010

Volltextzugriff (PDF)

1 – 25 von 749

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(546)
Mit Volltextzugriff
(610)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Reply: ‘Comment on Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)’

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions

Dose-dense therapy is of benefit in primary treatment of ovarian cancer? In favor

Docetaxel: an alternative taxane in ovarian cancer

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)

Association between blood omega-3 polyunsaturated fatty acids and the gut microbiota among breast cancer survivors

FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer

Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: An international collaborative meta-analysis

Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)

Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer

Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II–IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016)

Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)

Foraging areas of streaked shearwaters in relation to seasonal changes in the marine environment of the Northwestern Pacific: inter-colony and sex-related differences

Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy

Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus

A Phase III Trial of Paclitaxel plus Carboplatin Versus Paclitaxel plus Cisplatin in Stage IVB, Persistent or Recurrent Cervical Cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)

Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients

Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer

Comparison between triplet antiemetic study (TTT) and doublet antiemetic study (PROTECT): insights into the mechanisms of serotonin and aprepitant actions in chemotherapy induced nausea and vomiting

Investigator-Initiated Clinical Trials for New Drugs in Japan: Challenges and Perspectives

Can oncologists predict survival for patients with progressive disease after standard chemotherapies?

Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study

Compound Heterozygous Mutations in the Cholesterol Side-Chain Cleavage Enzyme Gene (CYP11A) Cause Congenital Adrenal Insufficiency in Humans

Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy

Suchergebnisse filtern